Skip to main content
. 2022 Jul 6;12(9):3456–3474. doi: 10.1016/j.apsb.2022.07.002

Table 1.

Licensed mucosal vaccines.

Type of vaccine Name Antigen Formulation Disease Administration Approved time Approved
Live attenuated122 OPV (b/m/tOPv) Poliovirus Aqueous Poliomyelitis123 Oral 1961 FDA
Subunit vaccine Dukoral® Vibrio cholerae124 rCTB Aqueous Cholera Oral 2003 Canada
Live attenuated Fluenz™/FluMist®125 lnfluenza A and influenza B viruses Spray Influenza Nasal 2003 FDA
Live reassortant126 RotaTeq® Rotavirus Aqueous Infant diarrhea Oral 2006 FDA
Live attenuated Rotarix RIX4414 strain127 Aqueous Infant diarrhea Oral 2008 FDA
Inactivated Euvichol128
Shanchol
Vibrio cholerae Aqueous Cholera Oral 2013 WHO
Live attenuated Vivotif®129 Salmonella typhimurium Capsule Acute gastroenteritis Oral 2013 FDA
Adenovirus vector vaccine130 Adenovirus Type 4 and Type 7 Vaccine Adenovirus Type 4 and Type 7 / Febrile acute respiratory disease Oral 2011 FDA
Live attenuated Vaxchora™ Vibrio cholerae131 Aqueous Cholera Oral 2015 FDA